Algorithmic Biologics Profile Photo

Algorithmic Biologics

(ALGORITHMIC BIOLOGICS PRIVATE LIMITED)

14 Published Patents

Founded in 2021

About Algorithmic Biologics

Algorithmic Biologics is a biotechnology startup that develops molecular computing solutions for diagnostics and research. It provides tools for next-generation sequencing, mass spectrometry, transcriptomics, drug screening, and PCR assay design.

Key Founders and Directors of Algorithmic Biologics

Key Focus Areas of Algorithmic Biologics

Metabolomic & Genetic Diseases Screening +2 more focus areas

Incubators & Accelerators of Algorithmic Biologics

Angel Networks & VC Investors of Algorithmic Biologics

+1 more fund

Frequently Asked Questions (FAQ)

When was Algorithmic Biologics founded?

Algorithmic Biologics was founded in the year 2021.

What is the legal name of Algorithmic Biologics?

The legal name of Algorithmic Biologics is Algorithmic Biologics Private Limited.

Who are the founders of Algorithmic Biologics?

Algorithmic Biologics is founded by Bhanu Priya Vaddiparthi and Manoj Gopalkrishnan.

Which VC Investors & Angel Networks funded Algorithmic Biologics?

Algorithmic Biologics is funded by VC Investors & Angel Networks like Axilor Ventures, Bengaluru and 1 other.

Which Incubators & Accelerators supported Algorithmic Biologics?

Algorithmic Biologics is supported by Google For Startups (Gfs) Accelerator India.

What are the focus areas of Algorithmic Biologics?

The key focus areas of Algorithmic Biologics are Metabolomic & Genetic Diseases Screening and 2 others.

Who are Algorithmic Biologics's competitors?

Possible competitors of Algorithmic Biologics may include Affigenix, Bioroot Exploration Pvt Ltd, Connexon Biosolutions and 7 others.

Get Access to Complete Information

Signup Now

YNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits